The leader in tissue simulation, CIRS, is recognized worldwide for tissue simulation technology and the manufacturing of phantoms and simulators for quantitative densitometry, calibration, quality control, and research in the field of medical imaging and radiotherapy.
Computerized Imaging Reference Systems (CIRS)
Founded in 1983, CIRS started out by seeking to improve the existing tissue simulation methodology and provide quantitative reference standards for computed tomography (CT).
Today, CIRS is recognized as a leader in the manufacturing of tissue-equivalent phantoms and simulators for medical imaging, radiotherapy, and procedural training.
CIRS is one of few companies worldwide with proprietary technology that permits the manufacture of phantoms for every commercial imaging modality. Applications include Original Equipment Manufacturer (OEM) production quality control, service, R&D, and pre-clinic trials. The company also provides custom design and manufacturing services to support research into new modalities and techniques.
CIRS employs a diverse group of people with specific knowledge in physics, computational modeling, chemistry, computer aided design, bio-modeling, tool and mold design, pattern making, resin casting, plastics fabrication, machining, electronics engineering, and software development.
Through global partnerships, CIRS, headquartered in Norfolk, VA (USA), distributes its products and services worldwide. Promotional efforts include tradeshows, website and internet marketing, an extensive worldwide network of independent manufacturing representatives, etc.
Within the scope of the industrial partnership, MEDITEST works closely with CIRS teams to develop new offers, such as specific phantoms.